메뉴 건너뛰기




Volumn 69, Issue 281, 1998, Pages 6-13

Rheumatoid arthritis. A paradigm of inflammatory disease of the musculoskeletal system

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIRHEUMATIC AGENT; CD5 MONOCLONAL ANTIBODY; COLLAGEN TYPE 2; CORTICOSTEROID; CYTOKINE; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2 DERIVATIVE; INTERLEUKIN 6 MONOCLONAL ANTIBODY; INTERLEUKIN 6 RECEPTOR ANTIBODY; LENERCEPT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 7; NONSTEROID ANTIINFLAMMATORY AGENT; OKT 4; P75 TUMOR NECROSIS FACTOR RECEPTOR FUSION PROTEIN; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 11; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

EID: 0032084223     PISSN: 03008827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (5)

References (39)
  • 1
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
    • Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Bloch, D.A.3
  • 2
    • 0029044711 scopus 로고
    • Health status instruments/utilities
    • Bellamy N, Boers M, Felson D et al. Health status instruments/utilities. J Rheumatol 1995; 22: 1203-7.
    • (1995) J Rheumatol , vol.22 , pp. 1203-1207
    • Bellamy, N.1    Boers, M.2    Felson, D.3
  • 3
    • 0030751946 scopus 로고    scopus 로고
    • Random comparison of combination step-down prednisolone, methotrexate and sulfasalazine with combination sulfasalazine alone in early rheumatoid arthritis
    • Boers M, Verhoeven AC, Markusse MH et al. Random comparison of combination step-down prednisolone, methotrexate and sulfasalazine with combination sulfasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 309-18.
    • (1997) Lancet , vol.350 , pp. 309-318
    • Boers, M.1    Verhoeven, A.C.2    Markusse, M.H.3
  • 4
    • 0029017921 scopus 로고
    • Gene therapy of rheumatoid arthritis via cytokine regulation : Future perspectives
    • Chernajovsky Y, Feldmann M, Maini RN. Gene therapy of rheumatoid arthritis via cytokine regulation : future perspectives. Br Med Bull 1995; 51: 503-16.
    • (1995) Br Med Bull , vol.51 , pp. 503-516
    • Chernajovsky, Y.1    Feldmann, M.2    Maini, R.N.3
  • 5
    • 0024538157 scopus 로고
    • Factors predicting a poor life prognosis in rheumatoid arthritis: An eight year prospective study
    • Erhardt CC, Mumford PA, Venables PJ, Maini RN. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis 1989; 48: 7-13.
    • (1989) Ann Rheum Dis , vol.48 , pp. 7-13
    • Erhardt, C.C.1    Mumford, P.A.2    Venables, P.J.3    Maini, R.N.4
  • 7
    • 0030996312 scopus 로고    scopus 로고
    • Anti-tumor necrosis factor-a therapy of rheumatoid arthritis
    • Feldmann M, Elliott MJ, Woody JN, Maini RN. Anti-tumor necrosis factor-a therapy of rheumatoid arthritis. Adv Immunol 1997;64:283-350.
    • (1997) Adv Immunol , vol.64 , pp. 283-350
    • Feldmann, M.1    Elliott, M.J.2    Woody, J.N.3    Maini, R.N.4
  • 8
    • 0026801236 scopus 로고
    • Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in RA
    • Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in RA. Arthritis Rheum. 1992; 35: 1117-25.
    • (1992) Arthritis Rheum , vol.35 , pp. 1117-1125
    • Felson, D.T.1    Anderson, J.J.2    Meenan, R.F.3
  • 9
    • 0029044362 scopus 로고
    • American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
    • Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-35.
    • (1995) Arthritis Rheum , vol.38 , pp. 727-735
    • Felson, D.T.1    Anderson, J.J.2    Boers, M.3
  • 10
    • 0020533315 scopus 로고
    • Toward an understanding of patient outcome measurement
    • Fries JF. Toward an understanding of patient outcome measurement. Arthritis Rheum 1983; 26: 697-704.
    • (1983) Arthritis Rheum , vol.26 , pp. 697-704
    • Fries, J.F.1
  • 11
    • 0025822870 scopus 로고
    • The hierarchy of quality-of-life assessment, the Health Assessment Questionnaire (HAQ), and issues mandating development of a toxicity index
    • Fries JF. The hierarchy of quality-of-life assessment, the Health Assessment Questionnaire (HAQ), and issues mandating development of a toxicity index. Controlled Clin Trials 1991; 12(4): 106S-117S.
    • (1991) Controlled Clin Trials , vol.12 , Issue.4
    • Fries, J.F.1
  • 12
    • 0000156797 scopus 로고
    • Medical costs are strongly associated with disability levels in rheumatoid arthritis
    • Fries JF, Williams CA, Ramey DR, Singh G. Medical costs are strongly associated with disability levels in rheumatoid arthritis. Arthritis Rheum 1995; 38: S187.
    • (1995) Arthritis Rheum , vol.38
    • Fries, J.F.1    Williams, C.A.2    Ramey, D.R.3    Singh, G.4
  • 14
    • 0025304539 scopus 로고
    • Rheumatoid arthritis: Pathophysiology and implications for therapy
    • Harris ED. Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277-89.
    • (1990) N Engl J Med , vol.322 , pp. 1277-1289
    • Harris, E.D.1
  • 15
    • 0024779849 scopus 로고
    • Rheumatoid arthritis as seen from official data registers: Experience in Finland
    • Isomaki HA. Rheumatoid arthritis as seen from official data registers: experience in Finland. Scan J Rheumatol 1989; 79: 21-4.
    • (1989) Scan J Rheumatol , vol.79 , pp. 21-24
    • Isomaki, H.A.1
  • 16
    • 0028089865 scopus 로고
    • Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five year period
    • Jacobsson LT, Hanson RL, Knowler WC, et al. Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five year period. Arthritis Rheum. 1994; 37: 1158-65.
    • (1994) Arthritis Rheum. , vol.37 , pp. 1158-1165
    • Jacobsson, L.T.1    Hanson, R.L.2    Knowler, W.C.3
  • 17
    • 0015922960 scopus 로고
    • Onset, early stages and prognosis of rheumatoid arthritis: A clinical study of 100 patients with 11 year follow-up
    • Jacoby RK, Jayson MIV, Cosh JA. Onset, early stages and prognosis of rheumatoid arthritis: A clinical study of 100 patients with 11 year follow-up. Br Med J 1973; 2: 96.
    • (1973) Br Med J , vol.2 , pp. 96
    • Jacoby, R.K.1    Jayson, M.I.V.2    Cosh, J.A.3
  • 18
    • 0029963281 scopus 로고    scopus 로고
    • Cost Evaluation of Novel Therapeutics in Rheumatoid Arthritis (CENTRA): A decision analysis model
    • Kavanaugh A, Deudebert G, Jain R, Cush J. Cost Evaluation of Novel Therapeutics in Rheumatoid Arthritis (CENTRA): A decision analysis model. Seminar Arthritis Rheum 1996; 25: 297-307.
    • (1996) Seminar Arthritis Rheum , vol.25 , pp. 297-307
    • Kavanaugh, A.1    Deudebert, G.2    Jain, R.3    Cush, J.4
  • 19
    • 0003068836 scopus 로고    scopus 로고
    • The EuroQol Instrument: An index of health-related quality of life
    • Spilker B, ed. Philadelphia: Lippincott-Raven
    • Kind P. The EuroQol Instrument: An index of health-related quality of life. In Spilker B, ed. Pharmacoeconomics and Quality of Life in Clinical Trials 2nd ed. Philadelphia: Lippincott-Raven, 1996: 191-201.
    • (1996) Pharmacoeconomics and Quality of Life in Clinical Trials 2nd Ed. , pp. 191-201
    • Kind, P.1
  • 20
    • 0018920615 scopus 로고
    • The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of the incidence, prevalence and mortality
    • Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of the incidence, prevalence and mortality. Am J Epidemiol 1980; 111: 87-98.
    • (1980) Am J Epidemiol , vol.111 , pp. 87-98
    • Linos, A.1    Worthington, J.W.2    O'Fallon, W.M.3    Kurland, L.T.4
  • 21
    • 0026722318 scopus 로고
    • A reappraisal of the measurement of disease occurrence in rheumatoid arthritis
    • Macgregor AJ, Silman AJ. A reappraisal of the measurement of disease occurrence in rheumatoid arthritis. Br J Rheumatol 1992; 19: 1163-1165.
    • (1992) Br J Rheumatol , vol.19 , pp. 1163-1165
    • Macgregor, A.J.1    Silman, A.J.2
  • 22
    • 7344241964 scopus 로고    scopus 로고
    • Immunomodulation of cytokines and T cells by biologicals in rheumatoid arthritis
    • Kresina TF, editor New York: Marcel Dekker Inc
    • Maini RN, Feldmann M. Immunomodulation of cytokines and T cells by biologicals in rheumatoid arthritis. In: Immune Modulating Agents, Kresina TF, editor New York: Marcel Dekker Inc; 1998a: 507-28.
    • (1998) Immune Modulating Agents , pp. 507-528
    • Maini, R.N.1    Feldmann, M.2
  • 23
    • 0004168844 scopus 로고    scopus 로고
    • Immunopathogenesis of rheumatoid arthritis
    • (Eds. Maddison PJ, Isenberg DA, Woo P, Glass DN) 2nd ed. Oxford University Press, Oxford
    • Maini RN, Feldmann M. Immunopathogenesis of rheumatoid arthritis. In: Oxford Textbook of Rheumatology, (Eds. Maddison PJ, Isenberg DA, Woo P, Glass DN) 2nd ed. Oxford University Press, Oxford 1998b: 983-1004.
    • (1998) Oxford Textbook of Rheumatology , pp. 983-1004
    • Maini, R.N.1    Feldmann, M.2
  • 24
    • 0026045957 scopus 로고
    • Worldwide trends in the socioeconomic, impact and long-term prognosis of rheumatoid arthritis
    • Markensen JA. Worldwide trends in the socioeconomic, impact and long-term prognosis of rheumatoid arthritis. 1991 Seminars Arthritis Rheum 21: 4.
    • (1991) Seminars Arthritis Rheum , vol.21 , pp. 4
    • Markensen, J.A.1
  • 25
    • 9244247260 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine or a combination of all three medications
    • O'Dell J, Haire C, Erikson N et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine or a combination of all three medications. N Engl J Med 1996; 334: 1287-91.
    • (1996) N Engl J Med , vol.334 , pp. 1287-1291
    • O'Dell, J.1    Haire, C.2    Erikson, N.3
  • 26
    • 0027474185 scopus 로고
    • What is the natural history of rheumatoid arthritis?
    • Pincus and L. F. Callahan, What is the natural history of rheumatoid arthritis? Rheum Dis Clin N America 1993; 19: 123-51.
    • (1993) Rheum Dis Clin N America , vol.19 , pp. 123-151
    • Pincus1    Callahan, L.F.2
  • 27
    • 70449217123 scopus 로고
    • 1958 revision of diagnostic criteria for rheumatoid arthritis
    • Ropes MW, Bennett GA, Cobb S et al. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175-6.
    • (1958) Bull Rheum Dis , vol.9 , pp. 175-176
    • Ropes, M.W.1    Bennett, G.A.2    Cobb, S.3
  • 28
    • 0031974911 scopus 로고    scopus 로고
    • Citrulline is an essential constituent on antigenic determinants recognized by rheumatoid arthritis specific autoantibodies
    • Schellekens GA, de Jong BAW, Frank HJ et al. Citrulline is an essential constituent on antigenic determinants recognized by rheumatoid arthritis specific autoantibodies. J Clin Invest 1998; 101: 273-81.
    • (1998) J Clin Invest , vol.101 , pp. 273-281
    • Schellekens, G.A.1    De Jong, B.A.W.2    Frank, H.J.3
  • 29
    • 0016248082 scopus 로고
    • The antiquity of rheumatoid arthritis
    • Short CL. The antiquity of rheumatoid arthritis. Arthritis Rheum. 1974; 17: 193-205.
    • (1974) Arthritis Rheum , vol.17 , pp. 193-205
    • Short, C.L.1
  • 31
    • 0001550784 scopus 로고    scopus 로고
    • Rheumatoid Arthritis: Classification and Epidemiology
    • (Eds. Klippel JH, Dieppe PA). 2nd ed. Mosby; London
    • Symmons D. Rheumatoid Arthritis: Classification and Epidemiology. In: Rheumatology, (Eds. Klippel JH, Dieppe PA). 2nd ed. Mosby; London 1998: 5: 1.1-30.2.
    • (1998) Rheumatology , vol.5
    • Symmons, D.1
  • 32
    • 0020436689 scopus 로고
    • The 1982 revised criteria for the classification of systemic lupus erythematosus
    • Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
    • (1982) Arthritis Rheum , vol.25 , pp. 1271-1277
    • Tan, E.M.1    Cohen, A.S.2    Fries, J.F.3
  • 33
    • 0029022389 scopus 로고
    • Combination therapy with with cyclosporine and methotrexate in severe rheumatoid arthritis
    • Tugwell P, Pincus T, Yocum D et al. Combination therapy with with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333: 137-41.
    • (1995) N Engl J Med , vol.333 , pp. 137-141
    • Tugwell, P.1    Pincus, T.2    Yocum, D.3
  • 34
    • 0029871565 scopus 로고    scopus 로고
    • Hemopoetic stem and progenitor cells in the treatment of severe auto-immune diseases
    • Tyndall A, Gratwohl A. Hemopoetic stem and progenitor cells in the treatment of severe auto-immune diseases. Ann Rheum Dis 1996; 55: 149-51.
    • (1996) Ann Rheum Dis , vol.55 , pp. 149-151
    • Tyndall, A.1    Gratwohl, A.2
  • 35
    • 0026630114 scopus 로고
    • Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients
    • van der Heijde, DMFM, van Riel, PLCM, van Leeuween, et al. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 1992; 31: 519-25.
    • (1992) Br J Rheumatol , vol.31 , pp. 519-525
    • Van Der Heijde, D.M.F.M.1    Van Riel, P.L.C.M.2    Van Leeuween3
  • 36
    • 0030737732 scopus 로고    scopus 로고
    • Currently used second-line agents; do they control the disease course?
    • van de Putte LBA, van Riel PLCM. Currently used second-line agents; do they control the disease course? Clin Exp Rheum 1997; 15: S71-S74.
    • (1997) Clin Exp Rheum , vol.15
    • Van De Putte, L.B.A.1    Van Riel, P.L.C.M.2
  • 37
    • 0030068817 scopus 로고    scopus 로고
    • Development and validation of the European League against rheumatism response criteria for rheumatoid arthritis
    • van Gestel AM, Prevoo MLL, van 'T Hof MA et al. Development and validation of the European League against rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum 1996; 39: 34-40.
    • (1996) Arthritis Rheum , vol.39 , pp. 34-40
    • Van Gestel, A.M.1    Prevoo, M.L.L.2    Van 'T Hof, M.A.3
  • 39
    • 0025934433 scopus 로고
    • The assessment and prediction of functional disability in rheumatoid arthritis
    • Wolfe F, Cathey MA. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol. 1991; 18: 1298-306.
    • (1991) J Rheumatol , vol.18 , pp. 1298-1306
    • Wolfe, F.1    Cathey, M.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.